ATE176671T1 - 16-kda-oberflächenprotein von p. falciparum - Google Patents

16-kda-oberflächenprotein von p. falciparum

Info

Publication number
ATE176671T1
ATE176671T1 AT91910355T AT91910355T ATE176671T1 AT E176671 T1 ATE176671 T1 AT E176671T1 AT 91910355 T AT91910355 T AT 91910355T AT 91910355 T AT91910355 T AT 91910355T AT E176671 T1 ATE176671 T1 AT E176671T1
Authority
AT
Austria
Prior art keywords
surface protein
falciparum
kda surface
protein
relates
Prior art date
Application number
AT91910355T
Other languages
English (en)
Inventor
Johannes Gerardus Schoenmakers
Rudolph Nicolaas Hendr Konings
Inge Irma Maria Domini Moelans
Original Assignee
Univ Nijmegen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nijmegen filed Critical Univ Nijmegen
Application granted granted Critical
Publication of ATE176671T1 publication Critical patent/ATE176671T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91910355T 1990-06-06 1991-06-01 16-kda-oberflächenprotein von p. falciparum ATE176671T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909012580A GB9012580D0 (en) 1990-06-06 1990-06-06 Novel protein

Publications (1)

Publication Number Publication Date
ATE176671T1 true ATE176671T1 (de) 1999-02-15

Family

ID=10677137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91910355T ATE176671T1 (de) 1990-06-06 1991-06-01 16-kda-oberflächenprotein von p. falciparum

Country Status (16)

Country Link
EP (1) EP0597843B1 (de)
JP (1) JP3066385B2 (de)
KR (1) KR930700544A (de)
AT (1) ATE176671T1 (de)
AU (1) AU641779B2 (de)
CA (1) CA2084673C (de)
DE (1) DE69130895T2 (de)
DK (1) DK0597843T3 (de)
ES (1) ES2127728T3 (de)
GB (1) GB9012580D0 (de)
GR (1) GR3029665T3 (de)
IE (1) IE911924A1 (de)
NZ (1) NZ238401A (de)
PT (1) PT97876B (de)
WO (1) WO1991018922A1 (de)
ZA (1) ZA914227B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9202026A (nl) * 1992-11-20 1994-06-16 Stichting Katholieke Univ Recombinant nuclëinezuur, daardoor gecodeerd polypeptide materiaal en daarop gebaseerd transmissie-blokkerend vaccin ter bestrijding van de malariaparasiet Plasmodium falciparum.
GB9616351D0 (en) * 1996-08-02 1996-09-11 Smithkline Beecham Biolog Vaccine composition
US6593463B1 (en) 1997-10-20 2003-07-15 Genzyme Transgenics Corporation Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems
US6828416B1 (en) 1998-08-21 2004-12-07 The United States Of America As Represented By The Department Of Health And Human Services Recombinant multivalent malarial vaccine against Plasmodium falciparum
GB0513421D0 (en) 2005-06-30 2005-08-03 Glaxosmithkline Biolog Sa Vaccines
CL2008002361A1 (es) 2007-08-13 2009-08-07 Glaxosmithkline Biologicals Sa Uso de un antigeno derivado de la proteina circumesporozoito (cs) de plasmodium falciparum que se expresa en la etapa preeritrocitica de la infeccion por malaria para tratar bebes contra la malaria.
US20120244178A1 (en) * 2011-03-25 2012-09-27 Denise Doolan Plasmodium falciparum antigens

Also Published As

Publication number Publication date
ZA914227B (en) 1992-03-25
EP0597843A1 (de) 1994-05-25
JP3066385B2 (ja) 2000-07-17
PT97876A (pt) 1992-04-30
DE69130895D1 (de) 1999-03-25
IE911924A1 (en) 1991-12-18
CA2084673A1 (en) 1991-12-07
NZ238401A (en) 1994-01-26
GR3029665T3 (en) 1999-06-30
WO1991018922A1 (en) 1991-12-12
AU641779B2 (en) 1993-09-30
AU7962991A (en) 1991-12-31
KR930700544A (ko) 1993-03-15
DK0597843T3 (da) 1999-09-20
EP0597843B1 (de) 1999-02-10
ES2127728T3 (es) 1999-05-01
GB9012580D0 (en) 1990-07-25
PT97876B (pt) 1998-10-30
JPH06500990A (ja) 1994-01-27
CA2084673C (en) 2002-07-30
DE69130895T2 (de) 1999-09-30

Similar Documents

Publication Publication Date Title
DE3583347D1 (de) Klonieren von dna fuer protozoenantigene.
ATE177755T1 (de) Hybrides protein zwischen cs aus plasmodium und hbsag
EA200401507A1 (ru) Межгенные области, используемые в качестве инсерционных сайтов в геноме модифицированного вируса коровьей оспы анкара (mva)
CA2231603A1 (en) Chicken interleukin-15 and uses thereof
KR890701758A (ko) 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
FR2697022B1 (fr) Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
DE69837390D1 (de) Rekombinanter schweine adenovirus vektor
DE3853139D1 (de) Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
PT534618E (pt) Peptidos para inducao de respostas de linfocitos t citotoxicos ao virus da hepatite b
DE69433007D1 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
DE69130895D1 (de) 16-kDa-OBERFLÄCHENPROTEIN VON P. FALCIPARUM
ITMI913092A1 (it) Vaccino di poxvirus ricombinante del virus del morbillo
YU12991A (sh) Rekombinantne vakcine protiv kokcidioze-5-7 eimeria površinski antigen
DE122005000015I1 (de) Azellul{rer Impfstoff.
MXPA02005506A (es) Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo.
CY1107784T1 (el) Πρωτεϊνη συντηξης g του ihnv για διεγερση του ανοσοποιητικου συστηματος
MY105313A (en) Malaria vaccine.
DE68926712D1 (de) Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff
DE69232460D1 (de) Die ansteckung blockierende malariaimpfstoffe
PT760394E (pt) Vacina de virus moderado da doenca de newcastle
WO1998040497A3 (en) An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
SE9702240D0 (sv) Vaccine compositions III
MX9101133A (es) Proteina novedosa capaz de inducir una respuesta inmune protectora contra la infeccion paludica humana causada por plasmodium falciparum

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee